BridgeMD
Tests treatment safety and results for Helicobacter Pylori Infection
Official title Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease
ClinicalTrials.gov ID: NCT07260006
What this study is testing
What is Bismuth quadruple therapy?
Bismuth quadruple therapy is an investigational medicine, being studied as a potential treatment for helicobacter pylori infection.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn if including bismuth in the treatment helps heal stomach and duodenal ulcers caused by Helicobacter pylori (H. pylori) in children.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 15
You may be able to join if
- Diagnosed with gastritis or peptic ulcer disease by upper gastrointestinal endoscopy or histopathology.
- Meets diagnostic criteria for Helicobacter pylori infection.
- Parent or legal guardian provides consent for the child to participate in the study.
You likely can't join if
- Allergic to any of the medications in the treatment regimen.
- Use of antibiotics or bismuth within the past 4 weeks, or use of antacids, H2-receptor antagonists, or proton pump inhibitors within the past 2 weeks.
- Failure to return for follow-up visits after treatment.
The study team makes the final eligibility decision.
Where it's taking place
- Can Tho, Vietnam
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 15 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Can Tho, Vietnam. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.